References
- Al Emran, A., Marzese, D.M., Menon, D.R., Stark, M.S., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Salomon, M.P., Nelson, N., et al. (2018). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget 9, 8206-8222. https://doi.org/10.18632/oncotarget.23654
- Barrett, C.S., Millena, A.C., and Khan, S.A. (2017). TGF-beta effects on prostate cancer cell migration and invasion require FosB. Prostate 77, 72-81. https://doi.org/10.1002/pros.23250
- Dhillon, A.S., Hagan, S., Rath, O., and Kolch, W. (2007). MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290. https://doi.org/10.1038/sj.onc.1210421
- Du, D., Katsuno, Y., Meyer, D., Budi, E.H., Chen, S.H., Koeppen, H., Wang, H., Akhurst, R.J., and Derynck, R. (2018). Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelialmesenchymal transition. EMBO Rep. 19, 135-155. https://doi.org/10.15252/embr.201744250
- Gajewski, P.A., Turecki, G., and Robison, A.J. (2016). Differential expression of FosB proteins and potential target genes in select brain regions of addiction and depression patients. PLoS One 11, e0160355. https://doi.org/10.1371/journal.pone.0160355
- Guo, J., Dai, X., Laurent, B., Zheng, N., Gan, W., Zhang, J., Guo, A., Yuan, M., Liu, P., Asara, J.M., et al. (2019). AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions. Nat. Cell Biol. 21, 226-237. https://doi.org/10.1038/s41556-018-0261-6
- Ho, Y.F., Karsani, S.A., Yong, W.K., and Abd Malek, S.N. (2013). Induction of apoptosis and cell cycle blockade by helichrysetin in a549 human lung adenocarcinoma cells. Evid. Based Complement. Alternat. Med. 2013, 857257.
- Huang, J., Huang, W., Liu, M., Zhu, J., Jiang, D., Xiong, Y., Zhen, Y., Yang, D., Chen, Z., Peng, L., et al. (2018). Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma. Oncol. Rep. 40, 1017-1025.
- Jin, H.O., Lee, Y.H., Park, J.A., Lee, H.N., Kim, J.H., Kim, J.Y., Kim, B., Hong, S.E., Kim, H.A., Kim, E.K., et al. (2014). Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells. J. Cancer Res. Clin. Oncol. 140, 2039-2046. https://doi.org/10.1007/s00432-014-1777-1
- Jin, H.O., Park, J.A., Kim, H.A., Chang, Y.H., Hong, Y.J., Park, I.C., and Lee, J.K. (2017). Piperlongumine downregulates the expression of HER family in breast cancer cells. Biochem. Biophys. Res. Commun. 486, 1083-1089. https://doi.org/10.1016/j.bbrc.2017.03.166
- Kim, J.A. (2018). Cooperative instruction of signaling and metabolic pathways on the epigenetic landscape. Mol. Cells 41, 264-270. https://doi.org/10.14348/MOLCELLS.2018.0076
- Lee, J.K. and Kim, K.C. (2013). DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Biochem. Biophys. Res. Commun. 438, 647-652. https://doi.org/10.1016/j.bbrc.2013.07.128
- Li, H., Li, L., Zheng, H., Yao, X., and Zang, W. (2016). Regulatory effects of DeltaFosB on proliferation and apoptosis of MCF-7 breast cancer cells. Tumor Biol. 37, 6053-6063. https://doi.org/10.1007/s13277-015-4356-4
- Liu, J.M., Pan, F., Li, L., Liu, Q.R., Chen, Y., Xiong, X.X., Cheng, K., Yu, S.B., Shi, Z., Yu, A.C., et al. (2013). Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem. Biophys. Res. Commun. 437, 87-93. https://doi.org/10.1016/j.bbrc.2013.06.042
- Lopez-Knowles, E., Wilkerson, P.M., Ribas, R., Anderson, H., Mackay, A., Ghazoui, Z., Rani, A., Osin, P., Nerurkar, A., Renshaw, L., et al. (2015). Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer. Breast Cancer Res. 17, 35. https://doi.org/10.1186/s13058-015-0532-0
- Na, H.H. and Kim, K.C. (2018). SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells. Biochem. Biophys. Res. Commun. 495, 512-518. https://doi.org/10.1016/j.bbrc.2017.10.176
- Na, H.H., Noh, H.J., Cheong, H.M., Kang, Y., and Kim, K.C. (2016). SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy. BMB Rep. 49, 238-243. https://doi.org/10.5483/BMBRep.2016.49.4.031
- Noh, H.J., Kim, K.A., and Kim, K.C. (2014). p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. Biochem. Biophys. Res. Commun. 446, 43-48. https://doi.org/10.1016/j.bbrc.2014.02.053
- Olcina, M.M., Leszczynska, K.B., Senra, J.M., Isa, N.F., Harada, H., and Hammond, E.M. (2016). H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene 35, 793-799. https://doi.org/10.1038/onc.2015.134
- Park, M.J., Lee, D.E., Shim, M.K., Jang, E.H., Lee, J.K., Jeong, S.Y., and Kim, J.H. (2017). Piperlongumine inhibits TGF-beta-induced epithelial-tomesenchymal transition by modulating the expression of E-cadherin, Snail1, and Twist1. Eur. J. Pharmacol. 812, 243-249. https://doi.org/10.1016/j.ejphar.2017.07.036
- Raj, L., Ide, T., Gurkar, A.U., Foley, M., Schenone, M., Li, X., Tolliday, N.J., Golub, T.R., Carr, S.A., Shamji, A.F., et al. (2011). Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475, 231-234. https://doi.org/10.1038/nature10167
- Regina, C., Compagnone, M., Peschiaroli, A., Lena, A., Annicchiarico-Petruzzelli, M., Piro, M.C., Melino, G., and Candi, E. (2016). Setdb1, a novel interactor of DeltaNp63, is involved in breast tumorigenesis. Oncotarget 7, 28836-28848. https://doi.org/10.18632/oncotarget.7089
- Rogalska, A., Szwed, M., and Rychlik, B. (2014). The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. Sci. World J. 2014, 819548.
- Ryu, T.Y., Kim, K., Kim, S.K., Oh, J.H., Min, J.K., Jung, C.R., Son, M.Y., Kim, D.S., and Cho, H.S. (2018). SETDB1 regulates SMAD7 expression for breast cancer metastasis. BMB Rep. 52, 139-144. https://doi.org/10.5483/bmbrep.2019.52.2.235
- Shahzad, M.M., Arevalo, J.M., Armaiz-Pena, G.N., Lu, C., Stone, R.L., Moreno-Smith, M., Nishimura, M., Lee, J.W., Jennings, N.B., Bottsford-Miller, J., et al. (2010). Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J. Biol. Chem. 285, 35462-35470. https://doi.org/10.1074/jbc.M110.109579
- Sun, Q.Y., Ding, L.W., Xiao, J.F., Chien, W., Lim, S.L., Hattori, N., Goodglick, L., Chia, D., Mah, V., Alavi, M., et al. (2015). SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway. J. Pathol. 235, 559-570. https://doi.org/10.1002/path.4482
- Tang, C., Jiang, Y., Shao, W., Shi, W., Gao, X., Qin, W., Jiang, T., Wang, F., and Feng, S. (2016). Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer. Int. J. Oncol. 49, 1489-1496. https://doi.org/10.3892/ijo.2016.3661
- Ting, C.H., Chen, Y.C., Wu, C.J., and Chen, J.Y. (2016). Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer. Oncotarget 7, 40329-40347. https://doi.org/10.18632/oncotarget.9612
- Ting, C.H., Lee, K.Y., Wu, S.M., Feng, P.H., Chan, Y.F., Chen, Y.C., and Chen, J.Y. (2019). FOSB(-)PCDHB13 axis disrupts the microtubule network in non-small cell lung cancer. Cancers 11, 107. https://doi.org/10.3390/cancers11010107
- Tkach, V., Tulchinsky, E., Lukanidin, E., Vinson, C., Bock, E., and Berezin, V. (2003). Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 22, 5045-5054. https://doi.org/10.1038/sj.onc.1206570
- Tulchinsky, E. (2000). Fos family members: regulation, structure and role in oncogenic transformation. Histol. Histopathol. 15, 921-928.
- Wang, S., He, M., Li, L., Liang, Z., Zou, Z., and Tao, A. (2016). Cell-in-cell death is not restricted by caspase-3 deficiency in MCF-7 cells. J. Breast Cancer 19, 231-241. https://doi.org/10.4048/jbc.2016.19.3.231
- Wong, C.M., Wei, L., Law, C.T., Ho, D.W., Tsang, F.H., Au, S.L., Sze, K.M., Lee, J.M., Wong, C.C., and Ng, I.O. (2016). Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. Hepatology 63, 474-487. https://doi.org/10.1002/hep.28304
- Wu, M., Fan, B., Guo, Q., Li, Y., Chen, R., Lv, N., Diao, Y., and Luo, Y. (2018). Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3prelated regulation. Biol. Res. 51, 39. https://doi.org/10.1186/s40659-018-0189-0
- Xiao, J.F., Sun, Q.Y., Ding, L.W., Chien, W., Liu, X.Y., Mayakonda, A., Jiang, Y.Y., Loh, X.Y., Ran, X.B., Doan, N.B., et al. (2018). The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis. J. Pathol. 246, 89-102. https://doi.org/10.1002/path.5126
- Yadav, S., Kalra, N., Ganju, L., and Singh, M. (2017). Activator protein-1 (AP-1): a bridge between life and death in lung epithelial (A549) cells under hypoxia. Mol. Cell. Biochem. 436, 99-110. https://doi.org/10.1007/s11010-017-3082-1
- Yang, L., Xia, L., Wu, D.Y., Wang, H., Chansky, H.A., Schubach, W.H., Hickstein, D.D., and Zhang, Y. (2002). Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21, 148-152. https://doi.org/10.1038/sj.onc.1204998
- Zhang, B., Shi, X., Xu, G., Kang, W., Zhang, W., Zhang, S., Cao, Y., Qian, L., Zhan, P., Yan, H., et al. (2017). Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53-dependent manner. J. Cell. Mol. Med. 21, 1329-1341. https://doi.org/10.1111/jcmm.13063
Cited by
- Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma vol.8, 2019, https://doi.org/10.3389/fbioe.2020.00266
- SOD1 Promotes Cell Proliferation and Metastasis in Non-small Cell Lung Cancer via an miR-409-3p/SOD1/SETDB1 Epigenetic Regulatory Feedforward Loop vol.8, 2019, https://doi.org/10.3389/fcell.2020.00213
- Piperlongumine Attenuates High Calcium/Phosphate-Induced Arterial Calcification by Preserving P53/PTEN Signaling vol.7, 2019, https://doi.org/10.3389/fcvm.2020.625215
- Structure, Activity and Function of the SETDB1 Protein Methyltransferase vol.11, pp.8, 2019, https://doi.org/10.3390/life11080817
- Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer vol.13, pp.17, 2019, https://doi.org/10.3390/cancers13174296
- Prognostic role of EGR1 in breast cancer: a systematic review vol.54, pp.10, 2019, https://doi.org/10.5483/bmbrep.2021.54.10.087
- The Natural Alkaloid Piperlongumine Inhibits Metastatic Activity and Epithelial-to-Mesenchymal Transition of Triple-Negative Mammary Carcinoma Cells vol.73, pp.11, 2021, https://doi.org/10.1080/01635581.2020.1825755